DIRS.INFO The most relevant business & tech news

☆ Investors are 'way too optimistic' about 2024, analyst says
▼ + stars: | 2024-01-26 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailInvestors are 'way too optimistic' about 2024, analyst saysJacob Pedersen, head of equity research at Sydbank, says global growth will be slower than in 2023.

Persons: Jacob Pedersen

☆ Wind power industry in moment of reckoning as stocks fall and earnings crumble
▼ + stars: | 2023-11-13 | by ( Elliot Smith | ) www.cnbc.com time to read: +5 min

Ina Fassbender | AFP | Getty ImagesRenewable energy firms are mostly suffering a dire earnings season as struggling supply chains, manufacturing faults and rising production costs eat into profits. Manufacturing faults, most notably at Siemens Energy 's wind turbine subsidiary Siemens Gamesa, have emerged as companies race to build turbines at a greater pace and scale. Specialist wind energy firms are also often finding themselves outbid for seabed licenses by traditional oil and gas players. As a result, most wind energy stocks are down sharply since the turn of the year. The firm's economists said the past earnings season was a "learning moment" for the industry.

Persons: Ina Fassbender, Ørsted, Vestas, Henrik Andersen, " Andersen, Jacob Pedersen, it's, " Pedersen, CNBC's, Pedersen Organizations: International Energy Agency, AFP, Getty, Siemens Energy, Siemens Gamesa, Allianz Research, CNBC Wednesday, Sydbank Locations: Germany, Europe, U.S

A view of the turbines at Orsted's offshore wind farm near Nysted, Denmark, September 4, 2023. Orsted, the world's largest offshore wind developer, said in August it may see impairments of 16 billion Danish crowns ($2.3 billion) on its U.S. offshore developments due to supply chain problems, soaring interest rates and a lack of new tax credits. Norway's Equinor (EQNR.OL), BP's partner on those New York offshore wind developments, booked a $300 million impairment on the projects on Friday. In Massachusetts, two offshore wind developers, SouthCoast Wind and Commonwealth Wind, agreed to pay local utilities to terminate deals that would have delivered around 2,400 MW of energy. Avangrid also canceled a contract to sell power in Connecticut from its proposed 804-MW Park City offshore wind farm.

Persons: Tom Little, Denmark's, Joe Biden, Orsted, Jacob Pedersen, Portugal, France's, Avangrid, Scott DiSavino, Louise Breusch Rasmussen, Ron Bousso, Jonathan Oatis, Josie Kao Organizations: REUTERS, BP, U.S, Analysts, Reuters, Commonwealth, Shell, Energias, Thomson Locations: Nysted, Denmark, U.S, Danish, New York, Massachusetts, Connecticut, Rhode Island and Massachusetts, In Massachusetts, Commonwealth, Spanish, Copenhagen, London, Bengaluru

☆ SAS slides 95% as Scandinavian airline's shareholders wiped out
▼ + stars: | 2023-10-04 | by ( Louise Rasmussen | ) www.reuters.com time to read: +2 min

COPENHAGEN, Oct 4 (Reuters) - SAS shares slumped by as much as 95% on Wednesday after the airline announced a financial restructuring on Tuesday to prevent bankruptcy, bringing on board big new investors and wiping out the stakes of its more than 250,000 owners. SAS (SAS.ST) said U.S. investment firm Castlelake and Air France-KLM (AIRF.PA) would become new major shareholders alongside the Danish state, and that the airline's stock will be delisted from the Stockholm, Copenhagen and Oslo exchanges. Scandinavian Airlines (SAS) flights are seen listed at Copenhagen Airport Kastrup in Copenhagen, Denmark, July 3, 2022. Shares in SAS, which have tumbled in recent years, traded down 83% at 1144 GMT to 0.05 Swedish crowns ($0.0045). "Management itself has come out to say there was a risk that the shares will become worthless.

Persons: Andrew Kelly, Lind, Jacob Pedersen, Pedersen, Louise Breusch Rasmussen, Anna Ringstrom, Terje Solsvik, Alexander Smith Organizations: SAS, Air France, KLM, France, Scandinavian Airlines, Copenhagen, REUTERS, Lind Invest, Thomson Locations: COPENHAGEN, United States, Danish, Stockholm, Copenhagen, Oslo, Amsterdam, Paris, Denmark

☆ Air France-KLM becoming a SAS shareholder will change dynamics amongst airlines, analyst says
▼ + stars: | 2023-10-04 | by ( ) www.cnbc.com time to read: 1 min

In this videoShare Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailAir France-KLM becoming a SAS shareholder will change dynamics amongst airlines, analyst saysJacob Pedersen, head of equity research at Sydbank, discusses the restructuring deal of the Scandinavian airline SAS, which includes fellow airline company Air France-KLM becoming a new major shareholder.

Persons: Jacob Pedersen Organizations: Email Air France, KLM, SAS, Scandinavian, Air France

SAS filed for U.S. bankruptcy protection last year as it struggled to slash costs and debt amid strikes by pilots. SAS hopes to raise 9.5 billion Swedish crowns ($863 million) in new equity and convert 20 billion crowns of debt into equity. They could include Sweden's family-owned Wallenberg foundation, which currently holds a 3.4% stake in SAS, or Danish pension funds, he said. Once that is done, SAS can begin proceedings to exit chapter 11 bankruptcy protection, which could be late this year or next year, Pedersen said. It is not clear if SAS will be taken off the Swedish stock market after exiting bankruptcy protection.

Persons: Johan Nilsson, Apollo, Jacob Pedersen, Gerald Engstrom, Pedersen, Johannes Birkebaek, Jacob Gronholt, Mark Potter Organizations: SAS Airbus, Kastrup, Scandinavian Airlines, TT News Agency, REUTERS, Rights, Scandinavia's, SAS, U.S, Italy's ITA Airways, Portugal's TAP, WHO, Apollo Global Management Inc, European Union, Wallenberg, Private, Lufthansa, ITA Airways, Thomson Locations: Kastrup, Denmark, Rights COPENHAGEN, Danish, Copenhagen, EU, Europe, SWEDEN, NORWAY, Swedish, Sweden, Private Swedish

☆ Airline SAS extends deadline for equity fundraising
▼ + stars: | 2023-09-11 | by ( ) www.reuters.com time to read: +2 min

TT News Agency/Johan Nilsson via REUTERS/File Photo Acquire Licensing RightsSept 11 (Reuters) - Scandinavian airline SAS (SAS.ST), battling to emerge from bankruptcy protection, said on Monday it was extending the deadline for final bids for its equity fundraising by a week to Sept. 25 at the request of bidders. SAS said in May the U.S. court had approved a revised plan to raise equity. Denmark has said it is willing to increase its stake in SAS to around 30% from around 22%, if others investors were to take a majority stake. Reuters reported in May that U.S. asset manager Apollo Global Management Inc (APO.N) planned to apply for approval from Swedish and Danish regulators to take a majority stake in SAS as part its rescue plan. Earlier this month, SAS, which has been under bankruptcy protection since July 2022, posted its first quarterly pretax profit since late 2019.

Persons: Johan Nilsson, Jacob Pedersen, Pedersen, Urvi Dugar, Gokul, David Evans, Mark Potter, Susan Fenton Organizations: SAS Airbus, Kastrup, Scandinavian Airlines, TT News Agency, REUTERS, Scandinavian, SAS, Reuters, Apollo Global Management Inc, Marie Mannes, Thomson Locations: Kastrup, Denmark, Sweden, Bengaluru, Stockholm

A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. The study called SELECT involved 17,500 patients aged 45 years or older with no prior history of diabetes and started almost five years ago testing if the weekly injection has medical benefits. The landmark trial data shows Wegovy has "the potential to change how obesity is regarded and treated," said Martin Holst Lange, executive vice president for development at Novo Nordisk, in a statement. Novo Nordisk said it expects to file for regulatory approvals of a label indication expansion for the weekly injection in the United States and European Union this year. The detailed results from the trial will be presented at a scientific conference later in 2023.

Persons: Jim Vondruska, Wegovy, Danish drugmaker, That's, Martin Holst Lange, Soren Lontoft Hansen, Novo, Maggie Fick, Nikolaj Skydsgaard, Josephine Mason, Sharon Singleton, Kirsten Donovan Organizations: REUTERS, COPENHAGEN, Novo Nordisk, Nordisk, European Union, World Health Organization, Barclays, Thomson Locations: Chicago , Illinois, U.S, LONDON, Danish, Europe's, United States, Europe, European, Norway, Denmark, Germany, Norwegian

A selection of injector pens for the Wegovy weight loss drug are shown in this photo illustration in Chicago, Illinois, U.S., March 31, 2023. The increasingly popular Wegovy has transformed the weight-loss market since its U.S. launch in June 2021, capturing the attention of patients, investors and celebrities worldwide. Novo's news lifted shares in Europe's second-most valuable listed company after LVMH (LVMH.PA) by more than 17% to record highs. Novo said the eagerly-awaited study results, which have not been peer reviewed, showed that patients on Wegovy had a 20% lower incidence of heart attack, stroke or death from heart disease compared to those on a placebo. Lilly's shares rose nearly 15% in early U.S. trading, boosted by its upbeat quarterly results and Novo's trial data.

Persons: Jim Vondruska, Novo, Wegovy, Jeff Levin, Willis, Willis Towers Watson, Martin Holst Lange, Novo's, Eli Lilly, Mounjaro, Soren Lontoft Hansen, Maggie Fick, Nikolaj Skydsgaard, Jacob Gronholt, Ludwig Burger, Patrick Wingrove, Terje Solsvik, Josephine Mason, Sharon Singleton, Kirsten Donovan, Jan Harvey, Alexander Smith Organizations: REUTERS, COPENHAGEN, Novo Nordisk, Willis Towers, U.S, Union, Pfizer Inc, Amgen Inc, World Health Organization, Barclays, Reuters, Pedersen, Thomson Locations: Chicago , Illinois, U.S, LONDON, Europe's, Europe, United States, Novo, Wegovy, Germany, Denmark, Norway, Copenhagen, Frankfurt, New York, Oslo

☆ Novo Nordisk shares slip on EMA drug safety signal
▼ + stars: | 2023-06-22 | by ( ) www.reuters.com time to read: +2 min

reported that the European Medicines Agency (EMA) had raised the safety signal, which is a way to monitor potential adverse events from the use of approved drugs. "Novo Nordisk is aware of the signal and the request by EMA and will deliver a thorough assessment of all relevant data to elucidate this topic," Lars Otto Andersen-Lange, media relations director at Novo Nordisk, told Reuters. report referred to a May 8 statement from EMA, which raised a thyroid cancer safety signal for several drugs in the GLP-1 class, including semaglutide. But a "causal association" between semaglutide and thyroid cancer had not been demonstrated in large-scale clinical trials and post-marketing surveillance, he said. EMA's safety signal had also included GLP-1 drugs from competitors Eli Lilly (LLY.N), Astrazeneca (AZN.L) and Sanofi (SASY.PA).

Persons: Lars Otto Andersen, Lange, Andersen, " Andersen, Eli Lilly, Soren Lontoft Hansen, Nikolaj Skydsgaard, Maggie Fick, Alexander Smith Organizations: Novo Nordisk, European Medicines Agency, EMA, Nordisk, Reuters, Astrazeneca, Sanofi, Thomson Locations: COPENHAGEN, Novo, Denmark's Novo, Copenhagen

☆ Novo Nordisk says EMA raised safety signal on drugs, shares fall
▼ + stars: | 2023-06-22 | by ( Nikolaj Skydsgaard | ) www.reuters.com time to read: +3 min

The European Medicines Agency (EMA) raised the safety signal, which is a way to monitor potential adverse events from the use of approved drugs. "Novo Nordisk is aware of the signal and the request by EMA and will deliver a thorough assessment of all relevant data to elucidate this topic," Lars Otto Andersen-Lange, media relations director at Novo Nordisk, told Reuters. reported the EMA safety signal. report referred to a May 8 statement from EMA, which raised a thyroid cancer safety signal for several drugs in the GLP-1 class, including semaglutide. EMA's safety signal also included GLP-1 drugs from competitors Eli Lilly (LLY.N), Astrazeneca (AZN.L) and Sanofi (SASY.PA).

Persons: Eli Lilly, Ozempic, Lars Otto Andersen, Lange, Andersen, " Andersen, Soren Lontoft Hansen, semaglutide, Nikolaj Skydsgaard, Maggie Fick, Alexander Smith Organizations: Sanofi, Novo Nordisk, European Medicines Agency, EMA, Nordisk, Reuters, Astrazeneca, FDA, Thomson Locations: Astrazeneca, COPENHAGEN, Denmark's Novo, Copenhagen

☆ Hackers hit websites of Danish central bank, other banks
▼ + stars: | 2023-01-10 | by ( ) www.reuters.com time to read: +1 min

COPENHAGEN, Jan 10 (Reuters) - Hackers have disrupted access to the websites of Denmark's central bank and seven private banks in the country this week, according to the central bank and an IT firm that serves the industry. The websites of the central bank and Bankdata, a company that develops IT solutions for the financial industry, were hit by so-called distributed denials of service (DDoS), which direct traffic towards targeted servers in a bid to knock them offline. A spokesperson for the central bank said its website was working normally on Tuesday afternoon and the attack did not impact the bank's other systems or day-to-day operations. Access to the websites of seven private banks was briefly restricted on Tuesday after the DDoS attack on Bankdata, a company spokesperson said. The banks included two of Denmark's largest, Jyske Bank (JYSK.CO) and Sydbank (SYDB.CO), he said.

☆ European shares rise on financials, energy boost amid festive cheer
▼ + stars: | 2022-12-22 | by ( Amruta Khandekar | ) www.reuters.com time to read: +3 min

The region-wide STOXX 600 index (.STOXX) was up 0.4% at a one-week high, taking cues from an upbeat session on Wall Street overnight. "What we're seeing is a recovery in risk appetite after a fairly negative set of central bank meetings for equities," said Adam Hoyes, markets economist at Capital Economics. The STOXX 600 (.STOXX) has fallen about 11% so far in 2022, but it has still outperformed the benchmark U.S. S&P 500 index (.SPX), which has declined 18.6% and is on track for its worst yearly performance since 2008. Euro zone bond yields struggled for direction on Thursday as investors took stock of a surge in borrowing costs in the wake of last week's European Central Bank (ECB) meeting. London's blue-chip FTSE 100 (.FTSE) rose 0.5% despite data showing Britain's economy contracted more than expected in the third quarter.

Search resuls for: "Sydbank"

13 mentions found